Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 11Observational 1

Sponsor

Cancer Type

Breast 10Tumor-Agnostic 1Classical hematology 1

Conditions

Neoplasm Metastasis 1

Interventions

Surveys and Questionnaires 48Blood Specimen Collection 22Interviews as Topic 14Data Collection 11Magnetic Resonance Spectroscopy 6Hematologic Tests 6Specimen Handling 5Restraint, Physical 5Radiotherapy 5Palliative Care 4Observation 4Mental Status and Dementia Tests 4Watchful Waiting 3Registries 3Quality of Life 3Phlebotomy 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Lapatinib 3Immunotherapy 3Immune Checkpoint Inhibitors 3Health Records, Personal 3Focus Groups 3Drug Therapy 3Bevacizumab 3Absorptiometry, Photon 3veliparib 2talazoparib 2rucaparib 2pamiparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × abemaciclib × Tumor-Agnostic × Clear all
NCT05789771 2023-03-31

ATLANT

Blokhin's Russian Cancer Research Center

Completed
136 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡